Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment

@article{Anand2017SafetyTA,
  title={Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment},
  author={Shweta Anand and Henry Hoi-Yee Tong and Frank M. C. Besag and Esther W Y Chan and Samuele Cortese and Ian C. K. Wong},
  journal={Pediatric Drugs},
  year={2017},
  volume={19},
  pages={235-250},
  url={https://api.semanticscholar.org/CorpusID:2220464}
}
Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects.
View on Springer Nature
eprints.soton.ac.uk
24 Citations
Highly Influential Citations
1
Results Citations
1

24 Citations

Pharmacological management for insomnia in children and adolescents with autism and attention deficit and hyperactivity disorder

It is important to determine when a pharmacological treatment can be indicated and which compound to prefer based on evidence of efficacy and safety, suggesting clinical advice that may guide clinicians.

Making sleep easier: pharmacological interventions for insomnia

In this review, the authors highlight basic physiological pathways of sleep regulation to understand fundamental pharmacological principles of sleep medicine and suggest focusing subjective sleep disturbances, such as superficial sleep perception, might help identify novel pathways.

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment

In children with ADHD with sleep problems after receiving MPH treatment, melatonin may be an effective and safe treatment, irrespective of gender, age and comorbidities.

Sleep disturbances in children and adolescents with attention-deficit/hyperactivity disorder: A narrative review.

Sleep disturbances and disorders are commonly associated with attention-deficit/hyperactivity disorder (ADHD), with affected children frequently experiencing delayed sleep onset, frequent nighttime…

Sleep problems in children and adolescents in an attention deficit hyperactivity disorder service

The need for both effective ADHD treatment and effective interventions for sleep problems to ensure optional sleep in young people are highlighted as well as effective interventions for sleep problems to prevent worsening of ADHD symptoms are highlighted.

Efficacy and safety of supplemental melatonin for delayed sleep–wake phase disorder in children: an overview

A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder

Evidence gaps remain as to a more accurate prevalence of ADHD, whether documented risk factors are causal, the efficacy of nonpharmacological treatments on any outcomes, and pharmacotherapy in mitigating the adverse outcomes associated with ADHD.

Pediatric Insomnia: Update and Future Directions

The high prevalence of pediatric insomnia, coupled with the low number of providers, highlights the urgent need for improving primary care practitioner awareness, while expanding alternative routes to access to care, such as interactive virtual technology-based treatments, parent education and manuals, along with ongoing efforts to increase professional training opportunities.

Trends in Pediatric Attention-Deficit Hyperactive Disorder Diagnoses and Prescription Utilization: 2016 to 2019

D diagnosis of ADHD among children is trending upward in the United States, and central nervous system stimulants are the most prescribed ADHD medications for children 17 years and younger.

Auricular acupressure for insomnia associated with attention deficit hyperactivity disorder: a case report

A case of a boy with ADHD who presented with insomnia that appeared to be effectively treated with Auricular acupressure is reported, considered a safe intervention for the management of several health conditions.

69 References

To Sleep or Not To Sleep: A Systematic Review of the Literature of Pharmacological Treatments of Insomnia in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.

Controlled Clinical Trial of Zolpidem for the Treatment of Insomnia Associated With Attention-Deficit/ Hyperactivity Disorder in Children 6 to 17 Years of Age

Zolpidem at a dose of 0.25 mg/kg per day to a maximum of 10 mg failed to reduce the latency to persistent sleep on polysomnographic recordings after 4 weeks of treatment in children and adolescents 6 through 17 years of age who had attention-deficit/hyperactivity disorder-associated insomnia.

Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder.

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.

It is suggested that clonidine may be an effective agent for sleep disturbances associated with ADHD, or its treatment, and warrant further controlled investigations.

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study

A dose of 3 mg melatonine reduces the time of falling asleep significantly in attention deficit/hyperactivity disorder (ADHD) subjects on methylphenidate treatment. Insomnia occurs in up to 54% in…

The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.

Since sleep problems are a common co-morbidity associated with ADHD, and because disturbed sleep may be linked etiologically to this disorder, L-theanine may represent a safe and important adjunctive therapy in childhood ADHD.

Eszopiclone for Insomnia Associated With Attention-Deficit/Hyperactivity Disorder

Ezopiclone (up to 3 mg) failed to reduce latency to persistent sleep on polysomnography after 12 weeks in children aged 6 to 17 years with ADHD-related insomnia.

Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial

Administration of melatonin along with methylphenidate can partially improve symptoms of sleep disturbance, however, it does not seem to reduce attention deficiency and hyperactivity behavior of children with ADHD.

Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management

This review aimed to provide the most updated information, preferably based on meta-analyses, systemic review, and randomized controlled trials published in the latest 3 years, in order to be clinically useful for practitioners and clinicians.

Sleep Problems in the Child with Attention-Deficit Hyperactivity Disorder

Whether metabolic or neurological pathways common to both sleep and ADHD may be disrupted, and whether targeting treatments to these pathways may simultaneously improve both ADHD and sleep symptoms, needs further elucidation.
...